Clinical Trial Update: Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of capecitabine, oxaliplatin, and radiation therapy for patients with stage I rectal cancer undergoing surgery; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-29